Le cluster Carcinoembryonic Antigen (immunology) - Colorectal Neoplasms (radionuclide imaging)
| 000253 (1992) | Volume rendering and bicolour scale in double isotope studies: application to immunoscintigraphy and bone landmarking. | |
| 000255 (1992) | Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence. | |
| 000183 (1997) | [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center]. | |
| 000198 (1996) | Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody. | |
| 000228 (1994) | Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate. | |
| 000279 (1990) | Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments. | |
| 000289 (1989) | Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies. | |
| 000084 (2007) | Pathology underrates colon cancer extranodal and nodal metastases; ex vivo radioimmunodetection helps staging. | |
| 000237 (1993) | Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay. | |
| 000244 (1993) | Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice. | |
| 000283 (1990) | Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody. | |
| 000288 (1989) | Immunoscintigraphy with indium-111 labeled monoclonal antibodies: the importance of a good display method. | |
| 000130 (2003) | Octreotide imaging plus bone scintigrams to optimally localize gastroenteropancreatic neuroendocrine tumors. | |
| 000140 (2002) | Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy. | |
| 000176 (1998) | Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. | |
| 000193 (1997) | Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. | |
| 000211 (1995) | Somatostatin receptor imaging: a preliminary experience in forty-nine patients. | |
| 000230 (1994) | Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma. | |
| 000248 (1993) | Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. | |
| 000258 (1992) | Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma. | |
| 000266 (1991) | Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients. | |
| 000316 (????) | Feasibility of radioimmunoguided surgery of colorectal carcinoma using indium 111 CEA specific antibody and simulation with a phantom using 2 steps targetting with bispecific antibody. | |
| 000007 (2013) | Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation. | |
| 000023 (2012) | Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement. | |
| 000037 (2011) | Feasibility of treating irradiated bone with intramedullary delivered autologous mesenchymal stem cells. | |
| 000039 (2011) | Contribution of SPECT/CT 111In-DTPA cisternography in the localization of an intermittent cerebrospinal fluid leak in a 3-year-old girl with congenital bone defect. | |
| 000041 (2011) | Biodistribution study of nanometric hybrid gadolinium oxide particles as a multimodal SPECT/MR/optical imaging and theragnostic agent. | |
| 000053 (2010) | First bodipy-DOTA derivatives as probes for bimodal imaging. | |
| 000086 (2007) | Intramyocardial Implantation of bone marrow-derived stem cells enhances perfusion in chronic myocardial infarction: dependency on initial perfusion depth and follow-up assessed by gated pinhole SPECT. | |
| 000139 (2002) | Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft. | |
| 000142 (2001) | Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. | |
| 000160 (1999) | Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections. | |
| 000165 (1999) | In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumors. | |
| 000166 (1999) | Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody. | |
| 000168 (1999) | Factor analysis of dynamic series (FADS) in somatostatin receptor imaging. | |
| 000184 (1997) | Utility of indium-111-antimyosin scintigraphy for diagnosis of myocardial damage in systemic sclerosis. | |
| 000185 (1997) | Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. | |
| 000194 (1996) | [Detection of endocrine tumors of the digestive tract. Value and limitations of scintigraphy of somatostatin receptors]. | |
| 000207 (1996) | Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. | |
| 000208 (1996) | Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques. | |
| 000236 (1993) | What factors determine indium-111 antimyosin monoclonal antibody uptake in patients with myocardial infarction? | |
| 000241 (1993) | Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. | |
| 000245 (1993) | Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic method. | |
| 000249 (1993) | Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. | |
| 000304 (1987) | A new approach to image subtraction in immunoscintigraphy: preliminary results. | |
| 000313 (????) | Indium-111 labeling of low density lipoproteins with the DTPA-bis(stearylamide): evaluation as a potential radiopharmaceutical for tumor localization. | |
| 000315 (????) | Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model. |
| This area was generated with Dilib version V0.5.76. |  |